Brighthouse Financial, Inc.

BHF

CIK 0001685040 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$1.69B
↑+40.2% +$484Mvs FY2024 (Q4)
Operating Income
$992M
↑+82.7% +$449Mvs FY2024 (Q4)
Net Income
$895M
↑+322.2% +$683Mvs FY2024 (Q4)
Gross Profit
$992M
↑+82.7% +$449Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
30/100
  • Profitability
    0Insufficient data
  • Liquidity
    0Insufficient data
  • Leverage
    77D/E 0.47 (under 0.5 = conservative)
  • Efficiency
    0Asset Turnover 0.03x (1.0+ = capital-efficient)
  • Growth
    100Revenue YoY +40.2% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Insufficient data

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project BHF's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$76.90
Total enterprise IV
$4.46B
Diluted shares
0.06B
Terminal PV
$3.23B (72% of total)
Year-5 FCF
$381M
YearProjected FCFDiscounted PV
+1$280M$254M
+2$302M$250M
+3$326M$245M
+4$352M$241M
+5$381M$236M
Terminal$5.20B$3.23B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Stock buybacks (TTM)
$102M
share count reduction

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$241.80B
everything owned
Total liabilities
$234.97B
everything owed
Stockholders' equity
$6.77B
shareholder claim
Net debt
$-1.64B
Net cash position ($1.64B)

Recent performance · 40 quarters

Revenue↑+40.2% +$484M
$1.69B
Net Income↑+172.2% +$303M
$479M
Free Cash Flow↑+387.5% +$93M
$117M

Drill down